J&J’s pivotal phase 3 study of Caplyta to treat manic episodes with or without mixed features in adults with bipolar I disorder meets its primary and key secondary endpoints: Ne ...
TG SAFE drugs wing raids unlicensed godown in Hanumakonda & seizes drugs worth Rs. 7.89 lakhs: Peethaambaran Kunnathoor, Chennai Thursday, November 12, 2026, 08:00 Hrs [IST] Inten ...
KPRDO cautions pharmacies on anti-cancer drug price reduction percentages: Nandita Vijayasimha, Bengaluru Thursday, November 12, 2026, 08:00 Hrs [IST] The Karnataka Pharma Retaile ...
The Central Drugs Standard Control Organisation (CDSCO) has once again requested the states and Union Territories (UTs) to onboard their officials and Drug Testing Laboratories (DTLs) on the ...
Industry seeks safeguards against automatic licence suspension over NSQ drug reports: Shardul Nautiyal, Mumbai Thursday, November 12, 2026, 08:00 Hrs [IST] Indian pharmaceutical i ...
Exports of Ayush and herbal products during the first six months of the current fiscal year have reported a decline of 1.48%, while imports registered a decline of 31.22% compared to the same period ...
Ribo submits European CTA for a novel dual targeting siRNA SR122 for mixed and severe dyslipidemia: Suzhou, China Wednesday, November 11, 2026, 18:00 Hrs [IST] Suzhou Ribo Life Sc ...
Roche to present new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026: Basel Wednesday, November 11, 2026, 11:00 Hrs [IST] ...
US FDA declines to approve Novocure’s Optune Mya to treat adult patients with brain metastases from NSCLC: Baar, Switzerland Wednesday, November 11, 2026, 14:00 Hrs [IST] Novocu ...
Merck reports positive results from phase 2b trial of efinopegdutide in adults with MASH and stage 2-3 fibrosis: Rahway, New Jersey Wednesday, November 11, 2026, 15:00 Hrs [IST] M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results